PL438131A1 - Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application - Google Patents
Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their applicationInfo
- Publication number
- PL438131A1 PL438131A1 PL438131A PL43813121A PL438131A1 PL 438131 A1 PL438131 A1 PL 438131A1 PL 438131 A PL438131 A PL 438131A PL 43813121 A PL43813121 A PL 43813121A PL 438131 A1 PL438131 A1 PL 438131A1
- Authority
- PL
- Poland
- Prior art keywords
- sub
- methoxy
- ethoxy
- substituted
- tetrahydropyridin
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Przedmiotem wynalazku są pochodne 5-podstawione-3-(1-aryloaliklo-1,2,3,6-tetrahydropirydyn-4-ylo)-1H-indolu o wzorze ogólnym 1, gdzie R<sub>1</sub> oznacza podstawnik fenyloctylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub R<sub>1</sub> oznacza podstawnik 4-metoksylenyloetylowy, natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik 4-fluorofenyloetylowy, natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik propylofenylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik butylofenylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowi lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik (2-okso-1H-benzo[b]oksin-3-ylo)metylo natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy oraz pochodne 5-podstawione-3-(1-alkilo-1,2,3,6-tetrahydropirydyn-4-ylo)-1H-indolu o wzorze ogólnym 1, gdzie R<sub>1</sub> oznacza podstawnik 2-metylopropylowy natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik izopropylowy natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub podstawnik etoksylowy. Związki będące przedmiotem wynalazku otrzymuje się w reakcji 5-podstawionych indoli z 1-alkiloarylo- lub 1-alkilopodstawionymi pochodnymi piperydyn-4-onu w metanolu w obecności wodorotlenku potasu. Reakcję prowadzi się przez 18 godzin w temperaturze wrzenia rozpuszczalnika. Mieszaninę reakcyjną pozostawia do swobodnej krystalizacji lub oziębia się, a po ochłodzeniu otrzymuje się osad produktu. Produkt reakcji oczyszcza się przez przemycie wodą, metanolem, eterem i rekrystalizuje się z odpowiedniego rozpuszczalnik,. korzystnie metanolu lub DMF albo oczyszcza metodami chromatograficznymi, korzystnie za pomocą chromatografii kolumnowej (żel krzemionkowy, gradient 2-5% bezw. NH<sub>3</sub> w MeOH/DCM). Związki według wynalazku będące wielocelowymi ligandami monoamin, w szczególności receptora dopaminowego D<sub>2</sub> oraz receptorów serotoninowych 5-HT<sub>1A</sub> i 5-HT<sub>2A</sub>, do zastosowania w leczeniu chorób psychicznych, w szczególności schizofrenii, choroby afektywnej dwubiegunowej i depresji.The subject of the invention are 5-substituted-3-(1-arylaalkyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives of the general formula 1, where R<sub>1</sub> is a substituent phenylethyl and R<sub>2</sub> is methoxy or R<sub>1</sub> is 4-methoxylenylethyl and R<sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is 4-fluorophenylethyl and R<sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is propylphenyl and R< sub>2</sub> means methoxy or ethoxy or R<sub>1</sub> means butylphenyl and R<sub>2</sub> means methoxy or ethoxy or R<sub>1< /sub> means (2-oxo-1H-benzo[b]oxin-3-yl)methyl and R<sub>2</sub> means hydrogen or methoxy or ethoxy and 5-substituted derivatives ne-3-(1-alkyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole of the general formula 1, where R<sub>1</sub> is a 2-methylpropyl substituent and R< sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is isopropyl and R<sub>2</sub> is methoxy or ethoxy. The compounds of the invention are prepared by reacting 5-substituted indoles with 1-alkylaryl- or 1-alkyl-substituted piperidin-4-one derivatives in methanol in the presence of potassium hydroxide. The reaction is carried out for 18 hours at the reflux temperature of the solvent. The reaction mixture is allowed to crystallize freely or is cooled and, on cooling, a precipitate of the product is obtained. The reaction product is purified by washing with water, methanol, ether and recrystallized from a suitable solvent. preferably methanol or DMF, or purified by chromatographic methods, preferably by column chromatography (silica gel, gradient 2-5% anhydrous NH<sub>3</sub> in MeOH/DCM). Compounds of the invention which are multitarget ligands of monoamines, in particular the dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, for use in in the treatment of mental illnesses, in particular schizophrenia, bipolar disorder and depression.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL438131A PL438131A1 (en) | 2021-06-11 | 2021-06-11 | Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL438131A PL438131A1 (en) | 2021-06-11 | 2021-06-11 | Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application |
Publications (1)
Publication Number | Publication Date |
---|---|
PL438131A1 true PL438131A1 (en) | 2022-12-12 |
Family
ID=84441507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL438131A PL438131A1 (en) | 2021-06-11 | 2021-06-11 | Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL438131A1 (en) |
-
2021
- 2021-06-11 PL PL438131A patent/PL438131A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2437755T3 (en) | Intermediates for thienopyrazole derivatives that have PDE 7 inhibitory activity | |
JP6770580B2 (en) | Pyrrolopyrimidine 5-membered ring aza cyclic derivative and its use | |
CA3009669C (en) | Bruton's tyrosine kinase inhibitors | |
Qin et al. | Metal-free catalyzed oxidative trimerization of indoles by using TEMPO in air: a biomimetic approach to 2-(1 H-indol-3-yl)-2, 3′-biindolin-3-ones | |
NO316564B1 (en) | Process for the preparation of imidazoquinolinamines | |
AU2013276519B2 (en) | 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents | |
CA2873925A1 (en) | 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents | |
CA2895430A1 (en) | Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents | |
JP2021532100A (en) | Further Substituted Triazoloquinoxaline Derivatives | |
JP2021532103A (en) | Substituted triazoloquinoxaline derivative | |
JP2021511299A (en) | New processes and intermediates for preparing soluble guanylate cyclase stimulants | |
JPH01268679A (en) | Production of 1-cyclopropyl-quinolone carboxylic acid and its derivative | |
PL438131A1 (en) | Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application | |
AU2011308256A1 (en) | Novel method of preparing benzoimidazole derivatives | |
CN104016969A (en) | N2-substituted 1,2,3-triazole derivative for Cu (I) ligand as well as preparation method and application of N2-substituted 1,2,3-triazole derivative | |
JP6256484B2 (en) | Method for producing pyridazine compound | |
US20050245750A1 (en) | Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative | |
PL438132A1 (en) | Substituted derivatives of 3-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, method of their preparation and their application | |
TW402593B (en) | Process for preparing 7-amincocarbonyl-tetrabenzodiazepines and intermediates | |
Misra et al. | In search of imidazo [1, 2-a] pyridine derivatives exhibiting resistance for catalytic hydrogenation | |
Raghavender et al. | Synthesis, Antibacterial Activity, and Cytotoxicity of Newly Synthesized N-Substituted 5, 6-Dimethoxy-1 H-indole Derivatives | |
KR101432427B1 (en) | Efficient synthesis of 3-hydroxy-2-oxindol derivatives by i_2 catalyzed reaction | |
PL438130A1 (en) | Derivatives of 5-substituted-3-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, method of their preparation and their applicatione | |
CA2461572C (en) | Polycyclic compounds having anti-tumor activity | |
Kovalskiy et al. | Synthesis of 7-(3-piperidyl)-[1, 6] naphthyridine and 7-(4-pipe-ridyl)[1, 6] naphthyridine. |